Login to Your Account



Start-Up Pharnext Raises €2.5M For Drug Repositioning Effort

By James Etheridge


Wednesday, December 12, 2007

No Abstract

 

BioWorld International Correspondent

PARIS - Pharnext, a start-up that is developing new treatments for severe neurological diseases, raised €2.5 million (US$3.68 million) in seed funding from the French venture capital firm Truffle Capital.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription